Evidence map›Paper›PMID 30255441›Full record

ArticleJournal of molecular neuroscience : MN2018

Association of MicroRNAs with the Clinicopathologic Characteristics of Ependymoma.

Mamoun Ahram, Justin Z Amarin, Haya H Suradi, Sultan S Abdelhamid, Mona M Makhamreh, Randa M Bawadi, Maysa Al-Hussaini

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mamoun AhramDepartment of Physiology and Biochemistry, School of Medicine, The University of Jordan, Amman, Jordan. m.ahram@ju.edu.jo.ORCID http://orcid.org/0000-0003-4457-3604
Justin Z AmarinSchool of Medicine, The University of Jordan, Amman, Jordan.
Haya H SuradiSchool of Medicine, The University of Jordan, Amman, Jordan.
Sultan S AbdelhamidSchool of Medicine, The University of Jordan, Amman, Jordan.
Mona M MakhamrehSchool of Medicine, The University of Jordan, Amman, Jordan.
Randa M BawadiDepartment of Physiology and Biochemistry, School of Medicine, The University of Jordan, Amman, Jordan.
Maysa Al-HussainiDepartment of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan.
University of Jordan · JOKing Hussein Cancer Center · JO

Funding

King Abdullah II Design and Development Bureau 15, 16King Abdullah II Fund for Development 15, 16
6 · The paper itself

Abstract

The current management of ependymoma is wrought with limitations. Molecular classification is a promising development. MicroRNA (miRNA) deregulation is associated with human cancer and may be a means of molecular classification. The aim of our study is to investigate the association of miRNA expression with the clinicopathologic characteristics of ependymoma. Twenty-two samples were clinically annotated. Histologic features were reassessed and the expression of Ki-67, cyclin D1, and nestin was examined. The expression of 84 stem cell-related miRNAs was profiled. The ΔΔC

Indexed as

AdolescentAdultAgedChildChild, PreschoolCyclin DEpendymomaFemaleHumansInfratentorial NeoplasmsKi-67 AntigenMaleMicroRNAsMiddle AgedNestinCyclin DKi-67 AntigenMicroRNAsNestinBiomarkersEpendymomaGene expression profilingMicroRNAsPCR ArrayReal-time PCR

Identifiers

PMID30255441
OpenAlexW2892780259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.